Spanish branches of aid groups Oxfam and Medecins Sans Frontieres on Tuesday handed in a petition with 250,000 signatures to the Spanish headquarters of Swiss pharmaceutical giant Novartis, urging the company to drop a patent dispute it is pursuing in India over a popular cancer drug.
Novartis, which makes the anti-leukemia drug Gleevec, has brought the civil case in a bid to prevent Indian firms from making generic versions of the medicine. If Novartis wins, "millions of people throughout the world may be left without essential medicines," Oxfam and Medecins Sans Frontieres -- or Doctors Without Frontiers -- said in a statement.
The petition was part of an international campaign being waged by the two aid groups.
Several Indian pharmaceutical companies make generic copies of Gleevec, which is also spelled Glivec, but sell it at a 10th of the US$2,600 price for a monthly dose charged by the Swiss company, the groups say.
The case is to be heard on Jan. 29 in India.
After a small protest outside Novartis offices in the northeastern city of Barcelona, aid group representatives met with company officials. They told reporters later that the meeting was cordial but that Novartis did not intend altering its stance.
On Tuesday, Novartis posted a statement on its Spanish Web site saying it offers Glivec free to 6,500 people in India, or 99 percent of those who receive the drug. The company also claims that generic copies are often put on sale at nearly five times the average Indian yearly salary, pushing it out of reach of the majority of people who need the drug.
MSF and other aid groups are supporting the Cancer Patients Aid Association, which offers treatment to some 40,000 Indian patients and has challenged Novartis' patent claim.
India's new patent law, which came into force Jan. 1, 2005, allows patents for products that represent new inventions after 1995 -- the year India joined the WTO, which regulates patent rules for member countries.
The pitch is a classic: A young celebrity with no climbing experience spends a year in hard training and scales Mount Everest, succeeding against some — if not all — odds. French YouTuber Ines Benazzouz, known as Inoxtag, brought the story to life with a two-hour-plus documentary about his year preparing for the ultimate challenge. The film, titled Kaizen, proved a smash hit on its release last weekend. Young fans queued around the block to get into a preview screening in Paris, with Inoxtag’s management on Monday saying the film had smashed the box office record for a special cinema
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
‘DISAPPEARED COMPLETELY’: The melting of thousands of glaciers is a major threat to people in the landlocked region that already suffers from a water shortage Near a wooden hut high up in the Kyrgyz mountains, scientist Gulbara Omorova walked to a pile of gray rocks, reminiscing how the same spot was a glacier just a few years ago. At an altitude of 4,000m, the 35-year-old researcher is surrounded by the giant peaks of the towering Tian Shan range that also stretches into China, Kazakhstan and Uzbekistan. The area is home to thousands of glaciers that are melting at an alarming rate in Central Asia, already hard-hit by climate change. A glaciologist, Omarova is recording that process — worried about the future. She hiked six hours to get to
The number of people in Japan aged 100 or older has hit a record high of more than 95,000, almost 90 percent of whom are women, government data showed yesterday. The figures further highlight the slow-burning demographic crisis gripping the world’s fourth-biggest economy as its population ages and shrinks. As of Sept. 1, Japan had 95,119 centenarians, up 2,980 year-on-year, with 83,958 of them women and 11,161 men, the Japanese Ministry of Health said in a statement. On Sunday, separate government data showed that the number of over-65s has hit a record high of 36.25 million, accounting for 29.3 percent of
RSS